FISHER MARY

SEC source: 0001493152-26-000700 · ownership.xml · derivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stock · 2,500 shares

Expires 2036-01-01

F1 · derivative.exercise_date: The shares underlying the option will vest in a series of twelve (12) successive substantially equal monthly installments, with the first installment vesting on the one month anniversary of the grant date and continuing to vest monthly thereafter, subject to Reporting Person's continuous service through each such vesting date.

SEC source: 0001654954-25-000693 · section16.xml · derivative · entry 2

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 196,851

Underlying: Common Stock · 196,851 shares

Expires not disclosed

F1 · kind: The shares of Common Stock and accompanying Warrant were purchased by the Reporting Person from the Issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d)(1) promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act").

F2 · price: The purchase price per share of Common Stock and accompanying Warrant was $1.27.

F3 · derivative.exercise_date: The Warrant will become exercisable beginning on the effective date of stockholder approval of the issuance of the shares of Common Stock issuable upon exercise of the warrants. The Warrant will expire five years from the effective date of stockholder approval. The Warrant cannot be exercised by the Reporting Person if, after giving effect thereto, the Reporting Person, together with his/her affiliates, would beneficially own, as determined in accordance with Section 13(d) of the Exchange Act, more than 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to such exercise, subject to certain exceptions.

F3 · derivative.expiration_date: The Warrant will become exercisable beginning on the effective date of stockholder approval of the issuance of the shares of Common Stock issuable upon exercise of the warrants. The Warrant will expire five years from the effective date of stockholder approval. The Warrant cannot be exercised by the Reporting Person if, after giving effect thereto, the Reporting Person, together with his/her affiliates, would beneficially own, as determined in accordance with Section 13(d) of the Exchange Act, more than 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to such exercise, subject to certain exceptions.

SEC source: 0001654954-25-000693 · section16.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 196,946

F1 · kind: The shares of Common Stock and accompanying Warrant were purchased by the Reporting Person from the Issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d)(1) promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act").

F2 · price: The purchase price per share of Common Stock and accompanying Warrant was $1.27.

SEC source: 0001654954-25-000400 · section16.xml · derivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2035-01-12

F1 · derivative.exercise_date: The shares underlying the option will vest in a series of twelve (12) successive substantially equal monthly installments, with the first installment vesting on the one month anniversary of the grant date and continuing to vest monthly thereafter, subject to Reporting Person's continuous service through each such vesting date.

SEC source: 0001654954-24-000298 · section16.xml · derivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2034-01-03

F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing January 4, 2024.

SEC source: 0001209191-23-038644 · doc4.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,581

F1 · shares: The Restricted Stock Units shall vest on the earlier to occur of: (i) the day prior to the 2024 Annual Shareholders Meeting or (ii) on the one (1) year anniversary of the Annual Shareholders Meeting on which the Restricted Stock Award was granted, subject to continued service.

SEC source: 0001654954-22-013527 · section16.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,443

F1 · date: On October 6, 2022, the Reporting Person was granted 9,810 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan.

SEC source: 0001654954-22-009452 · section16.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,633

F1 · shares: On July 7, 2022, the Reporting Person was granted 8,602 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan.

SEC source: 0001209191-22-036502 · doc4.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 179,147

F1 · shares: The Restricted Stock Units shall vest on the earlier to occur of: (i) the day prior to the 2023 Annual Shareholders Meeting or (ii) on the one (1) year anniversary of the Annual Shareholders Meeting on which the Restricted Stock Award was granted, subject to continued service.

SEC source: 0000905718-22-000570 · dermata_fm4apr72022.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,031

F1 · shares: On April 7, 2022, the Reporting Person was granted 5,031 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan.

SEC source: 0000905718-22-000040 · dermata_fm4jan32022.xml · derivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2032-01-02

F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing January 3, 2022.

SEC source: 0000905718-21-001100 · dermata_fm4aug172021.xml · derivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2031-08-17

F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing September 17, 2021.

SEC source: 0001209191-21-040776 · doc4.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,841

F1 · shares: The Restricted Stock Units shall vest on the earlier to occur of: (i) the day prior to the 2022 Annual Shareholders Meeting or (ii) on the one (1) year anniversary of the Annual Shareholders Meeting on which the Restricted Stock Award was granted, subject to continued service.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of Sientra, Inc. Class A Common Stock.

SEC source: 0001209191-20-035386 · doc4.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,971

F1 · shares: The Restricted Stock Units (RSUs) will vest on the earlier to occur of: (i) the day prior to the Annual Meeting for the fiscal year following the date of grant or (ii) the one (1) year anniversary of the Annual Meeting on which the Annual Grant was granted, subject to continued service as a director of the Issuer.

SEC source: 0001209191-19-037856 · doc4.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,254

F1 · shares: The Restricted Stock Units (RSUs) will vest on the earlier to occur of: (i) the day prior to the Annual Meeting for the fiscal year following the date of grant or (ii) the one (1) year anniversary of the Annual Meeting on which the Annual Grant was granted, subject to continued service as a director of the Issuer.

SEC source: 0001209191-19-003361 · doc4.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,934

F1 · shares: The Restricted Stock Units (RSUs) vest in three (3) equal annual installments beginning January 1, 2019 subject to the Reporting Person's continued service.

SEC source: 0001209191-18-062108 · doc4.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,319

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

F2 · shares: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.

F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

F2 · balance_after: Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018.

SEC source: 0001179110-18-011955 · edgar.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,460

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

SEC source: 0001179110-18-009534 · edgar.xml · derivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2028-07-04

F1 · derivative.exercise_date: The stock option will vest in twelve equal monthly installments at the end of each successive month following July 4, 2018.

SEC source: 0001179110-18-009348 · edgar.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,609

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

SEC source: 0001179110-18-005302 · edgar.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,099

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

SEC source: 0001179110-18-000449 · edgar.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,934

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

F1 · price: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

SEC source: 0001179110-17-013054 · edgar.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,363

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

SEC source: 0001179110-17-010100 · edgar.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,842

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

SEC source: 0001179110-17-009557 · edgar.xml · derivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2027-06-21

F1 · derivative.exercise_date: The stock option will vest in twelve equal monthly installments at the end of each successive month following June 21, 2017.

SEC source: 0001209191-17-028603 · doc4.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Disposed of pursuant to the Agreement and Plan of Merger, dated as of February 13, 2017, by and among Allergan Holdco US, Inc., a wholly owned subsidiary of Allergan plc ("Allergan"), Blizzard Merger Sub, Inc. ("Merger Sub"), and the Issuer (the "Merger Agreement"), as approved by the board of directors of the Issuer, whereby Merger Sub merged with and into the Issuer, with the Issuer continuing on as the surviving corporation (the "Merger").

F2 · kind: Pursuant to the terms of the Merger Agreement, out of the total of 10,122 shares held by the Reporting Person, (i) 9,089 shares were canceled and converted into the right to receive $56.50 per share in cash, without interest and subject to any applicable withholding of taxes, and (ii) 1,033 shares, representing unvested restricted stock units, were converted into a corresponding award of restricted stock units with respect to ordinary shares of Allergan, on the same terms and conditions as were applicable under such restricted stock units, as adjusted based on an exchange ratio.

F1 · price: Disposed of pursuant to the Agreement and Plan of Merger, dated as of February 13, 2017, by and among Allergan Holdco US, Inc., a wholly owned subsidiary of Allergan plc ("Allergan"), Blizzard Merger Sub, Inc. ("Merger Sub"), and the Issuer (the "Merger Agreement"), as approved by the board of directors of the Issuer, whereby Merger Sub merged with and into the Issuer, with the Issuer continuing on as the surviving corporation (the "Merger").

F2 · price: Pursuant to the terms of the Merger Agreement, out of the total of 10,122 shares held by the Reporting Person, (i) 9,089 shares were canceled and converted into the right to receive $56.50 per share in cash, without interest and subject to any applicable withholding of taxes, and (ii) 1,033 shares, representing unvested restricted stock units, were converted into a corresponding award of restricted stock units with respect to ordinary shares of Allergan, on the same terms and conditions as were applicable under such restricted stock units, as adjusted based on an exchange ratio.

SEC source: 0001179110-17-005739 · edgar.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,637

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

SEC source: 0001179110-17-000418 · edgar.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,964

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.

SEC source: 0001179110-16-030319 · edgar.xml · nonDerivative · entry 1

FISHER MARY · CIK 0001272360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,697

F1 · kind: The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan.